Xylopine
Based on 1 Customer Validation
Xylopine is an aporphine alkaloid with cytotoxic activity on cancer cells. Xylopine induces oxidative stress, causes G2/M cell cycle arrest and apoptosis in cancer cells.
For research use only. We do not sell to patients.
- Purity: 98.0%
- CAS No.: 517-71-5
- Formula: C18H17NO3
- Molecular Weight:295.33
-
Storage:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A-431 | ED50 |
4.6 μg/mL
Compound: 5
|
Cytotoxicity against human A431 cells after 3 days by SRB assay
Cytotoxicity against human A431 cells after 3 days by SRB assay
|
[PMID: 8254346] |
| HT-1080 | ED50 |
2.2 μg/mL
Compound: 5
|
Cytotoxicity against human HT1080 cells after 3 days by SRB assay
Cytotoxicity against human HT1080 cells after 3 days by SRB assay
|
[PMID: 8254346] |
| KB | ED50 |
2 μg/mL
Compound: 5
|
Cytotoxicity against human KB cells after 3 days by SRB assay
Cytotoxicity against human KB cells after 3 days by SRB assay
|
[PMID: 8254346] |
| KB-V1 | ED50 |
0.9 μg/mL
Compound: 5
|
Cytotoxicity against vinblastine-resistant human KBV1 cells after 3 days by SRB assay
Cytotoxicity against vinblastine-resistant human KBV1 cells after 3 days by SRB assay
|
[PMID: 8254346] |
| LNCaP | ED50 |
2.4 μg/mL
Compound: 5
|
Cytotoxicity against human LNCAP cells after 3 days by SRB assay
Cytotoxicity against human LNCAP cells after 3 days by SRB assay
|
[PMID: 8254346] |
| P388 | ED50 |
2.2 μg/mL
Compound: 5
|
Cytotoxicity against mouse P388 cells after 3 days by SRB assay
Cytotoxicity against mouse P388 cells after 3 days by SRB assay
|
[PMID: 8254346] |
| SK-MEL-2 | ED50 |
12.6 μg/mL
Compound: 5
|
Cytotoxicity against human SK-MEL-2 cells after 3 days by SRB assay
Cytotoxicity against human SK-MEL-2 cells after 3 days by SRB assay
|
[PMID: 8254346] |
| U-373MG ATCC | ED50 |
1.9 μg/mL
Compound: 5
|
Cytotoxicity against human U373 cells after 3 days by SRB assay
Cytotoxicity against human U373 cells after 3 days by SRB assay
|
[PMID: 8254346] |
| ZR-75-1 | ED50 |
2.4 μg/mL
Compound: 5
|
Cytotoxicity against human ZR-75-1 cells after 3 days by SRB assay
Cytotoxicity against human ZR-75-1 cells after 3 days by SRB assay
|
[PMID: 8254346] |
Xylopine (3.5 μM-14 μM; 24-48 hours) displays potent cytotoxicity in a time- and does-depenpent manner[1].
Xylopine (72 h) has cytotoxic activity, with IC50 values ranging from 6.4 to 26.6 μM in eight different cancer cell lines (MCF7, HCT116, HepG2, SCC-9, HSC-3, HL-60, K-562, and B16-F10)[1].
Xylopine (3.5 μM-14 μM; 24-48 hours) causes cell cycle block at the phase G2/M, which is followed by internucleosomal DNA fragmentation[1].
Xylopine (3.5 μM-14 μM; 24-48 hours) significantly increases the early and late apoptosis, induces mitochondrial depolarization, and increases caspase-3 activation[1].
Xylopine also causes an increase in the production of reactive oxygen/nitrogen species (ROS/RNS), including hydrogen peroxide and nitric oxide, but not superoxide anion, and reduces glutathione levels are decreased in Xylopine-treated HCT116 cells[1].
HCT116 cells[1]
3.5 μM, 7 μM, and 14 μM
24 hours, 48 hours
Induced G2/M phase arrest.
HCT116 cells[1]
3.5 μM, 7 μM, and 14 μM
24 hours, 48 hours
Significantly increased the early and late apoptosis.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCT116 cells
-
Concentration:3.5 μM, 7 μM, and 14 μM
-
Incubation Time:24 hours, 48 hours
-
Result:Displayed potent cytotoxicity in HCT116 cells.
-
Cell Line:HCT116 cells
-
Concentration:3.5 μM, 7 μM, and 14 μM
-
Incubation Time:24 hours, 48 hours
-
Result:Induced G2/M phase arrest.
-
Cell Line:HCT116 cells
-
Concentration:3.5 μM, 7 μM, and 14 μM
-
Incubation Time:24 hours, 48 hours
-
Result:Significantly increased the early and late apoptosis.
Chemical Information
-
CAS No. 517-71-5
-
Appearance Solid
-
Molecular Weight 295.33
-
Formula C18H17NO3
-
Color Light yellow to yellow
-
SMILES
COC1=CC=C2C3=C4C(CCN[C@]4([H])CC2=C1)=CC5=C3OCO5
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Solvent & Solubility
DMSO : 50 mg/mL (169.30 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 1.25 mg/mL (4.23 mM); Clear solution
This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 1.25 mg/mL (4.23 mM); Clear solution
This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (278 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.3860 mL | 16.9302 mL | 33.8604 mL | 84.6511 mL |
| 5 mM | 0.6772 mL | 3.3860 mL | 6.7721 mL | 16.9302 mL | |
| 10 mM | 0.3386 mL | 1.6930 mL | 3.3860 mL | 8.4651 mL | |
| 15 mM | 0.2257 mL | 1.1287 mL | 2.2574 mL | 5.6434 mL | |
| 20 mM | 0.1693 mL | 0.8465 mL | 1.6930 mL | 4.2326 mL | |
| 25 mM | 0.1354 mL | 0.6772 mL | 1.3544 mL | 3.3860 mL | |
| 30 mM | 0.1129 mL | 0.5643 mL | 1.1287 mL | 2.8217 mL | |
| 40 mM | 0.0847 mL | 0.4233 mL | 0.8465 mL | 2.1163 mL | |
| 50 mM | 0.0677 mL | 0.3386 mL | 0.6772 mL | 1.6930 mL | |
| 60 mM | 0.0564 mL | 0.2822 mL | 0.5643 mL | 1.4109 mL | |
| 80 mM | 0.0423 mL | 0.2116 mL | 0.4233 mL | 1.0581 mL | |
| 100 mM | 0.0339 mL | 0.1693 mL | 0.3386 mL | 0.8465 mL |
Xylopine Related Classifications
HY-N9534 Related Classifications
Powered by Bioz